These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5031151)

  • 1. [Comparative study of the anticoagulant properties of 2 derivatives of 4-hydroxycoumarin].
    Thonnart N; Bourgain R; Reuse JJ
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):408-11. PubMed ID: 5031151
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant activity of Heraclenin.
    Mishra KC; Sharma RC; Sharma YN; Arora RB
    Indian J Physiol Pharmacol; 1969 Jul; 13(3):153-5. PubMed ID: 5362630
    [No Abstract]   [Full Text] [Related]  

  • 3. Species differences in the anticoagulant activities of aflatoxin B 1 and 4-hydroxycoumarin.
    Bababunmi EA; Bassir O
    Afr J Med Sci; 1972 Apr; 3(2):97-103. PubMed ID: 4623912
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
    Migne J; Monteil R; Pessereau G; Pernod J; Siau J
    Therapie; 1968; 23(3):553-66. PubMed ID: 5740621
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on 4-hydroxy-I-thiacoumarins: VI--anticoagulant activity and chemical structure in 4-hydroxy-I-thiacoumarins and related compounds.
    Jamkhandi PS; Rajagopal S; Sirsi M
    Indian J Exp Biol; 1968 Oct; 6(4):224-6. PubMed ID: 5720680
    [No Abstract]   [Full Text] [Related]  

  • 6. The standardization of the prothrombin time for the control of anticoagulant therapy.
    Biggs R
    Thromb Diath Haemorrh Suppl; 1968; 35():87-92. PubMed ID: 5761075
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacodynamics of the oral anticoagulant drugs.
    O'Reilly RA
    Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives.
    Abdelhafez OM; Amin KM; Batran RZ; Maher TJ; Nada SA; Sethumadhavan S
    Bioorg Med Chem; 2010 May; 18(10):3371-8. PubMed ID: 20435480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anticoagulant activity of 3.3'-(p-alkylthio-benzylidene)-bis-4-hydroxycoumarins and their oxidation products.
    Gumińska M; Eckstein M; Stachurska B; Sulko J
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):277-86. PubMed ID: 5584958
    [No Abstract]   [Full Text] [Related]  

  • 10. The anticoagulant activity of 3-1-phenyl-propyl-4-hydroxycoumarin in patients on "long-term" therapy.
    Bourgain RH; Vanden Driessche R; Smets P
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):240-6. PubMed ID: 5015934
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of 3-amino-4-hydroxy coumarin and dihydroxy-phenyl coumarins as novel anticoagulants.
    Danis O; Yuce-Dursun B; Gunduz C; Ogan A; Sener G; Bulut M; Yarat A
    Arzneimittelforschung; 2010; 60(10):617-20. PubMed ID: 21125812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticoagulant action of a new synthetic derivative of 4-hydroxycoumarin and antagonism by synthetic vitamin K1 in the rat].
    Thonnart N; Letist D; Reuse JJ
    C R Seances Soc Biol Fil; 1973; 167(6):1081-5. PubMed ID: 4803162
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of nitrazepam on oral anticoagulation with phenprocoumon.
    Bieger R; de Jonge H; Loeliger EA
    Clin Pharmacol Ther; 1972; 13(3):361-5. PubMed ID: 4554660
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of Echis carinata venom on hemostasis].
    Zimmermann H; Habermann E; Lasch HG
    Thromb Diath Haemorrh; 1971 Jun; 25(3):425-37. PubMed ID: 5561955
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anticoagulant activity of newly synthetized 6-fluoro-4-hydroxycoumarin derivatives].
    Dezelić M; Trkovnik M; Jovanović V; Huković S
    Acta Med Iugosl; 1965; 19(2):142-51. PubMed ID: 5872174
    [No Abstract]   [Full Text] [Related]  

  • 16. [Slope of decrease of coagulation factors during anticoagulant therapy (tioclomarol) (author's transl)].
    Valty J; Dumoulin P; Vergoz D; Rozenstajn L; Ferrer F; Jaillon P
    Therapie; 1980; 35(5):613-8. PubMed ID: 7209858
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anticoagulant of indirect action nitropharin].
    Lakin KM; Smirnova TV; Karaseva MG
    Farmakol Toksikol; 1968; 31(2):184-7. PubMed ID: 5674673
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of pyrazolidine and coumarin derivatives on bleeding time and prothrombin level in rats.
    Cepeláková H; Roubal Z; Grimová J; Dlabac A; Cepelák V
    Acta Univ Carol Med Monogr; 1972; 52():55-60. PubMed ID: 4669827
    [No Abstract]   [Full Text] [Related]  

  • 19. [Attempted demonstration of a circulating anticoagulant in subjects treated with 5-phenyl-propyl-4-hydroxycoumarin].
    Bourgain RH; Kahn MJ
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):483-5. PubMed ID: 5367315
    [No Abstract]   [Full Text] [Related]  

  • 20. Laboratory control of anticoagulant therapy.
    Poller L
    Semin Thromb Hemost; 1986 Jan; 12(1):13-9. PubMed ID: 3961505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.